{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:17:37Z","timestamp":1785863857840,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:00:00Z","timestamp":1729900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41390-024-03642-1","type":"journal-article","created":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T00:03:23Z","timestamp":1729901003000},"page":"2449-2453","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Desmopressin dosing in children using real-world data and pharmacokinetic\/pharmacodynamic model simulations"],"prefix":"10.1038","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-3633","authenticated-orcid":false,"given":"Kevin","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shylaja","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,26]]},"reference":[{"key":"3642_CR1","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1210\/clinem\/dgac381","volume":"107","author":"M Tomkins","year":"2022","unstructured":"Tomkins, M., Lawless, S., Martin-Grace, J., Sherlock, M. & Thompson, C. J. Diagnosis and management of central diabetes insipidus in adults. J. Clin. Endocrinol. Metab. 107, 2701\u20132715 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3642_CR2","doi-asserted-by":"crossref","unstructured":"Teare, H. et al. Challenges and improvement needs in the care of patients with central diabetes insipidus. Orphanet J. Rare Dis. 17, 58 (2022).","DOI":"10.1186\/s13023-022-02191-2"},{"key":"3642_CR3","doi-asserted-by":"crossref","unstructured":"Driano, J. E., Lteif, A. N. & Creo, A. L. Vasopressin-dependent disorders: what is new in children? Pediatrics 147, e2020022848 (2021).","DOI":"10.1542\/peds.2020-022848"},{"key":"3642_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101440","volume":"34","author":"G Patti","year":"2020","unstructured":"Patti, G. et al. Central diabetes insipidus in children: Diagnosis and management. Best. Pract. Res. Clin. Endocrinol. Metab. 34, 101440 (2020).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"3642_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00228-022-03297-z","volume":"78","author":"X Chin","year":"2022","unstructured":"Chin, X. et al. Desmopressin therapy in children and adults: pharmacological considerations and clinical implications. Eur. J. Clin. Pharm. 78, 907\u2013917 (2022).","journal-title":"Eur. J. Clin. Pharm."},{"key":"3642_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1515\/jpem-2013-0078","volume":"26","author":"HL Ooi","year":"2013","unstructured":"Ooi, H. L., Maguire, A. M. & Ambler, G. R. Desmopressin administration in children with central diabetes insipidus: a retrospective review. J. Pediatr. Endocrinol. Metab. 26, 1047\u20131052 (2013).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"3642_CR7","unstructured":"Desmopressin: Pediatric drug information - UpToDate. https:\/\/www-uptodate-com.ucsf.idm.oclc.org\/contents\/desmopressin-pediatric-drug-information?search=desmopressin&source=panel_search_result&selectedTitle=2~122&usage_type=panel&kp_tab=drug_pediatric&display_rank=1#F157850."},{"key":"3642_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpeds.2021.08.087","volume":"239","author":"N Almutlaq","year":"2021","unstructured":"Almutlaq, N. & Eugster, E. A. Variability in oral desmopressin dose requirements in children with central diabetes insipidus. J. Pediatr. 239, 228\u2013230 (2021).","journal-title":"J. Pediatr."},{"key":"3642_CR9","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1038\/psp.2013.71","volume":"3","author":"RN Upton","year":"2014","unstructured":"Upton, R. N. & Mould, D. R. Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods. CPT Pharmacomet. Syst. Pharm. 3, e88 (2014).","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"3642_CR10","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1038\/psp.2012.4","volume":"1","author":"DR Mould","year":"2012","unstructured":"Mould, D. R. & Upton, R. N. Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacomet. Syst. Pharm. 1, e6 (2012).","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"3642_CR11","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1038\/psp.2013.14","volume":"2","author":"DR Mould","year":"2013","unstructured":"Mould, D. R. & Upton, R. N. Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacomet. Syst. Pharm. 2, e38 (2013).","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"3642_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s40262-015-0340-9","volume":"55","author":"JS McCune","year":"2016","unstructured":"McCune, J. S., Bemer, M. J. & Long-Boyle, J. Pharmacokinetics, pharmacodynamics, and pharmacogenomics of immunosuppressants in allogeneic hematopoietic cell transplantation: Part II. Clin. Pharmacokinet. 55, 551\u2013593 (2016).","journal-title":"Clin. Pharmacokinet."},{"key":"3642_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S2352-4642(19)30196-8","volume":"3","author":"KK Radtke","year":"2019","unstructured":"Radtke, K. K. et al. Evaluation of dosing guidelines for childhood tuberculosis: a mathematical modeling study. Lancet Child Adolesc. Health 3, 636\u2013645 (2019).","journal-title":"Lancet Child Adolesc. Health"},{"key":"3642_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/cpt.2238","volume":"110","author":"E Hughes","year":"2021","unstructured":"Hughes, E., Wallender, E., Mohamed Ali, A., Jagannathan, P. & Savic, R. M. Malaria PK\/PD and the role pharmacometrics can play in the global health arena: malaria treatment regimens for vulnerable populations. Clin. Pharm. Ther. 110, 926\u2013940 (2021).","journal-title":"Clin. Pharm. Ther."},{"key":"3642_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40262-019-00798-6","volume":"59","author":"R Michelet","year":"2020","unstructured":"Michelet, R. et al. An integrated paediatric population PK\/PD analysis of dDAVP: how do PK differences translate to clinical outcomes? Clin. Pharmacokinet. 59, 81\u201396 (2020).","journal-title":"Clin. Pharmacokinet."},{"key":"3642_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1515\/jpem-2022-0058","volume":"35","author":"E Gasimova","year":"2022","unstructured":"Gasimova, E. et al. Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus. J. Pediatr. Endocrinol. Metab. 35, 1089\u20131096 (2022).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"3642_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpem-2012-0006","volume":"25","author":"G Catli","year":"2012","unstructured":"Catli, G. et al. Clinical profile and etiologies of children with central diabetes insipidus: a single-center experience from Turkey. J. Pediatr. Endocrinol. Metab. 25, 499\u2013502 (2012).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"3642_CR18","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1210\/jc.2015-1287","volume":"100","author":"D Werny","year":"2015","unstructured":"Werny, D., Elfers, C., Perez, F. A., Pihoker, C. & Roth, C. L. Pediatric central diabetes insipidus: brain malformations are common and few patients have idiopathic disease. J. Clin. Endocrinol. Metab. 100, 3074\u20133080 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3642_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2015.04.013","volume":"29","author":"N Di Iorgi","year":"2015","unstructured":"Di Iorgi, N. et al. Management of diabetes insipidus and adipsia in the child. Best. Pract. Res. Clin. Endocrinol. Metab. 29, 415\u2013436 (2015).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"3642_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1651-2227.1997.tb14858.x","volume":"86","author":"EM Boulgourdjian","year":"1997","unstructured":"Boulgourdjian, E. M., Mart\u00ednez, A. S., Ropelato, M. G., Heinrich, J. J. & Bergad\u00e1, C. Oral desmopressin treatment of central diabetes insipidus in children. Acta Paediatr. 86, 1261\u20131262 (1997).","journal-title":"Acta Paediatr."},{"key":"3642_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40272-020-00401-7","volume":"22","author":"E Gasthuys","year":"2020","unstructured":"Gasthuys, E. et al. Pediatric pharmacology of desmopressin in children with enuresis: a comprehensive review. Pediatr. Drugs 22, 369\u2013383 (2020).","journal-title":"Pediatr. Drugs"},{"key":"3642_CR22","first-page":"293","volume":"83","author":"S Edate","year":"2015","unstructured":"Edate, S. & Albanese, A. Management of electrolyte and fluid disorders after brain surgery for pituitary\/suprasellar tumours. HRP 83, 293\u2013301 (2015).","journal-title":"HRP"},{"key":"3642_CR23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1210\/clinem\/dgab930","volume":"107","author":"G Patti","year":"2022","unstructured":"Patti, G. et al. Approach to the pediatric patient: central diabetes insipidus. J. Clin. Endocrinol. Metab. 107, 1407\u20131416 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3642_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S2213-8587(22)00219-4","volume":"10","author":"C Atila","year":"2022","unstructured":"Atila, C. et al. Central diabetes insipidus from a patient\u2019s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. Lancet Diabetes Endocrinol. 10, 700\u2013709 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3642_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.5489\/cuaj.5263","volume":"12","author":"LA Guerra","year":"2018","unstructured":"Guerra, L. A., Keays, M. A., Purser, M. J., Wang, S. Y. & Leonard, M. P. Pediatric cystogram: Are we considering age-adjusted bladder capacity? Can. Urol. Assoc. J. 12, 378\u2013381 (2018).","journal-title":"Can. Urol. Assoc. J."},{"key":"3642_CR26","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/S0022-5347(01)68230-2","volume":"158","author":"M Kaefer","year":"1997","unstructured":"Kaefer, M. et al. Estimating normal bladder capacity in children. J. Urol. 158, 2261\u20132264 (1997).","journal-title":"J. Urol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03642-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03642-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:11:57Z","timestamp":1757117517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03642-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3642"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03642-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,26]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Institutional Review Board of University of California San Francisco. Informed consent was waived by Institutional Review Board as data for this study were generated from retrospective review of clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and informed consent"}}]}}